Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896766 · ClinicalTrials.gov registry record
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 150
- Enrollment target
NCT00896766: Completed study, sponsored by Children's Oncology Group.
NCT00896766 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896766 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at lymphoblasts in young patients with high-risk acute lymphoblastic leukemia.
Interventions
- GENETIC microarray analysis
- GENETIC polymorphism analysis
- GENETIC tumor replication error analysis
- GENETIC loss of heterozygosity analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2006-05 |
| Est. Completion | 2016-05 |
What the finished NCT00896766 record still lists
NCT00896766 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which microarray analysis is the first listed.
NCT00896766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00896766 about?
NCT00896766 is a clinical study titled "Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia". RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at lymphoblasts in young patie...
What is the current status of trial NCT00896766?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2006-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00896766?
The interventions under investigation include: microarray analysis (GENETIC), polymorphism analysis (GENETIC), tumor replication error analysis (GENETIC), loss of heterozygosity analysis (GENETIC).
Who is sponsoring clinical trial NCT00896766?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia